UPC orders 17-country ban on EOFlow's pumps in Insulet feud

Appeals court overturns lower court ruling in decision establishing key standards for patent interpretation | Global dispute between the two insulin pump makers intensifies amid separate US trade secret litigation.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

Medical company sees $452m trade secrets award cut by 87%

29 April 2025 US district judge reduces award payable to Insulet by EOFlow to $59.4m l Dispute concerns wearable insulin patch pumps l Injunction remains but with allowance for users to access device temporarily.

Americas

‘A marathon and a sprint at the same time’: How we won $452m damages

12 December 2024 With 27 witnesses, plus both patent infringement and misappropriation claims, lead counsel for Insulet Alexandra Valenti and Scott Bluni share ‘a milestone’ in DTSA case law.

Americas

EOFlow ordered to pay rival $452m over insulin patch trade secrets

5 December 2024 Jury finds medical device company misappropriated secrets covering Insulet’s Omnipod l Insulet “extremely pleased” with verdict l Federal circuit overturned ban on EOFlow’s product in June.

More on this story

Americas

Medical company sees $452m trade secrets award cut by 87%

Americas

‘A marathon and a sprint at the same time’: How we won $452m damages

12 December 2024 With 27 witnesses, plus both patent infringement and misappropriation claims, lead counsel for Insulet Alexandra Valenti and Scott Bluni share ‘a milestone’ in DTSA case law.

Americas

EOFlow ordered to pay rival $452m over insulin patch trade secrets

More on this story

Americas

Medical company sees $452m trade secrets award cut by 87%

Americas

‘A marathon and a sprint at the same time’: How we won $452m damages

12 December 2024 With 27 witnesses, plus both patent infringement and misappropriation claims, lead counsel for Insulet Alexandra Valenti and Scott Bluni share ‘a milestone’ in DTSA case law.

Americas

EOFlow ordered to pay rival $452m over insulin patch trade secrets